{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:45:12Z","timestamp":1793832312178,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81700584"],"award-info":[{"award-number":["81700584"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13054-019-2317-9","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T06:05:10Z","timestamp":1548309910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiren","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"2317_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/cc9358","volume":"15","author":"HM Oudemans-van Straaten","year":"2011","unstructured":"Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate? Crit Care. 2011;15:202.","journal-title":"Crit Care"},{"key":"2317_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13054-016-1299-0","volume":"20","author":"C Liu","year":"2016","unstructured":"Liu C, Mao Z, Kang H, Hu J, Zhou F. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care. 2016;20:144.","journal-title":"Crit Care"},{"key":"2317_CR3","first-page":"123","volume":"109","author":"R Apsner","year":"1997","unstructured":"Apsner R, Schwarzenhofer M, Derfler K, Zauner C, Ratheiser K, Kranz A. Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr. 1997;109:123\u20137.","journal-title":"Wien Klin Wochenschr"},{"key":"2317_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/00003246-200104000-00010","volume":"29","author":"HU Meier-Kriesche","year":"2001","unstructured":"Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med. 2001;29:748\u201352.","journal-title":"Crit Care Med"},{"key":"2317_CR5","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","volume":"31","author":"L Kramer","year":"2003","unstructured":"Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med. 2003;31:2450\u20135.","journal-title":"Crit Care Med"},{"key":"2317_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease","year":"2012","unstructured":"Kidney Disease. Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guidelines for acute kidney injury. Kidney Int Suppl. 2012;2:1\u2013138.","journal-title":"Kidney Int Suppl"},{"key":"2317_CR7","first-page":"45","volume-title":"Blood purification standard operating procedure (SOP)","author":"X Chen","year":"2010","unstructured":"Chen X. Anticoagulation in blood purification: contraindications. In: Sun X, Ding X, Liu F, Liu Z, Chen J, Mei C, editors. Blood purification standard operating procedure (SOP). Beijing: PEOPLE'S MILITARY MEDICAL PRESS; 2010. p. 45."},{"key":"2317_CR8","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc11363","volume":"16","author":"A Link","year":"2012","unstructured":"Link A, Klingele M, Speer T, Rbah R, Poss J, Lerner-Graber A, et al. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care. 2012;16:R97.","journal-title":"Crit Care"},{"key":"2317_CR9","doi-asserted-by":"publisher","first-page":"R162","DOI":"10.1186\/cc11485","volume":"16","author":"C Schultheiss","year":"2012","unstructured":"Schultheiss C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, et al. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care. 2012;16:R162.","journal-title":"Crit Care"},{"key":"2317_CR10","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jcrc.2015.06.006","volume":"30","author":"T Lahmer","year":"2015","unstructured":"Lahmer T, Messer M, Rasch S, Beitz A, Schnappauf C, Schmid RM, et al. Sustained low-efficiency dialysis with regional citrate anticoagulation in medical intensive care unit patients with liver failure: a prospective study. J Crit Care. 2015;30:1096\u2013100.","journal-title":"J Crit Care"},{"key":"2317_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13054-015-1066-7","volume":"19","author":"T Slowinski","year":"2015","unstructured":"Slowinski T, Morgera S, Joannidis M, Henneberg T, Stocker R, Helset E, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care. 2015;19:349.","journal-title":"Crit Care"},{"key":"2317_CR12","unstructured":"GA. W, B. S, D. OC. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In: Clinical epidemiology program. The Ottawa Hospital Research Institute. 2011. \nhttp:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n\n. Accessed 15 Apr 2018."},{"key":"2317_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"2317_CR14","unstructured":"JPS. H, S G, (editors). Cochrane Handbook for Systematic Reviews of Intervention. In: Version 5.1.0 (Table 7.7.a) [updated March 2011]. The Cochrane Collaboration. 2011. \nhttp:\/\/handbook-5-1.cochrane.org\/\n\n. Accessed 25 Apr 2018."},{"key":"2317_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"2317_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/CNQ.0000000000000118","volume":"39","author":"R Wonnacott","year":"2016","unstructured":"Wonnacott R, Josephs B, Jamieson J. CRRT regional anticoagulation using citrate in the liver failure and liver transplant population. Crit Care Nurs Q. 2016;39:241\u201351.","journal-title":"Crit Care Nurs Q"},{"key":"2317_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.transproceed.2017.02.025","volume":"49","author":"N Pertica","year":"2017","unstructured":"Pertica N, Cicciarella L, Carraro A, Montin U, Violi P, Lupo A, et al. Safety and efficacy of citrate anticoagulation for continuous renal replacement therapy for acute kidney injury after liver transplantation: a single-center experience. Transplant Proc. 2017;49:674\u20136.","journal-title":"Transplant Proc"},{"key":"2317_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/1744-9987.12196","volume":"19","author":"C Sponholz","year":"2015","unstructured":"Sponholz C, Settmacher U, Bauer M, Kortgen A. Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience. Ther Apher Dial. 2015;19:8\u201315.","journal-title":"Ther Apher Dial"},{"key":"2317_CR19","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1097\/CCM.0b013e31818b9100","volume":"36","author":"MS Durao","year":"2008","unstructured":"Durao MS, Monte JC, Batista MC, Oliveira M, Iizuka IJ, Santos BF, et al. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury. Crit Care Med. 2008;36:3024\u20139.","journal-title":"Crit Care Med"},{"key":"2317_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/1744-9987.12280","volume":"19","author":"P Vico De","year":"2015","unstructured":"De Vico P, Messino V, Tartaglione A, Beccaris C, Buonomo C, Talarico D, et al. Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction. Ther Apher Dial. 2015;19:272\u20138.","journal-title":"Ther Apher Dial"},{"key":"2317_CR21","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/ndt\/gfr510","volume":"27","author":"FH Saner","year":"2012","unstructured":"Saner FH, Treckmann JW, Geis A, Losch C, Witzke O, Canbay A, et al. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy. Nephrol Dial Transplant. 2012;27:1651\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"2317_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5301\/JN.2011.8363","volume":"25","author":"RA Balogun","year":"2012","unstructured":"Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM. Regional citrate anticoagulation in critically ill patients with liver and kidney failure. J Nephrol. 2012;25:113\u20139.","journal-title":"J Nephrol"},{"key":"2317_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13054-017-1870-3","volume":"21","author":"M Klingele","year":"2017","unstructured":"Klingele M, Stadler T, Fliser D, Speer T, Groesdonk HV, Raddatz A. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Crit Care. 2017;21:294.","journal-title":"Crit Care"},{"key":"2317_CR24","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1159\/000491057","volume":"43","author":"Y Yu","year":"2018","unstructured":"Yu Y, Peng S, Cen Z, Cai J, Wang W, Tang Y, et al. Applying regional citrate anticoagulation in continuous renal replacement therapy for acute kidney injury patients with acute liver dysfunction: a retrospective observational study. Kidney Blood Press Res. 2018;43:1065\u201374.","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"2317_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1055\/s-2002-23205","volume":"22","author":"L Amitrano","year":"2002","unstructured":"Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis. 2002;22(1):83\u201396.","journal-title":"Semin Liver Dis"},{"key":"2317_CR26","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","volume":"137","author":"A Tripodi","year":"2009","unstructured":"Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009;137:2105\u201311.","journal-title":"Gastroenterology"},{"key":"2317_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/hep.23653","volume":"52","author":"A Tripodi","year":"2010","unstructured":"Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell'Era A, Iannuzzi F, et al. Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology. 2010;52:249\u201355.","journal-title":"Hepatology"},{"key":"2317_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jhep.2009.05.028","volume":"51","author":"B Agarwal","year":"2009","unstructured":"Agarwal B, Shaw S, Shankar Hari M, Burroughs AK, Davenport A. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different? J Hepatol. 2009;51:504\u20139.","journal-title":"J Hepatol"},{"key":"2317_CR29","first-page":"744.e747","volume":"27","author":"HR Chua","year":"2012","unstructured":"Chua HR, Baldwin I, Bailey M, Subramaniam A, Bellomo R. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure. J Crit Care. 2012;27:744.e747\u201315.","journal-title":"J Crit Care"},{"key":"2317_CR30","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/ki.1990.300","volume":"38","author":"RL Mehta","year":"1990","unstructured":"Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 1990;38:976\u201381.","journal-title":"Kidney Int"},{"key":"2317_CR31","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1046\/j.1523-1755.1999.00444.x","volume":"55","author":"R Palsson","year":"1999","unstructured":"Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int. 1999;55:1991\u20137.","journal-title":"Kidney Int"},{"key":"2317_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S0272-6386(00)70248-4","volume":"35","author":"DJ Kutsogiannis","year":"2000","unstructured":"Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis. 2000;35:802\u201311.","journal-title":"Am J Kidney Dis"},{"key":"2317_CR33","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00134-002-1443-y","volume":"28","author":"L Gabutti","year":"2002","unstructured":"Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med. 2002;28:1419\u201325.","journal-title":"Intensive Care Med"},{"key":"2317_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","volume":"30","author":"M Monchi","year":"2004","unstructured":"Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med. 2004;30:260\u20135.","journal-title":"Intensive Care Med"},{"key":"2317_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-015-0822-z","volume":"19","author":"F Stucker","year":"2015","unstructured":"Stucker F, Ponte B, Tataw J, Martin PY, Wozniak H, Pugin J, et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care. 2015;19:91.","journal-title":"Crit Care"},{"key":"2317_CR36","first-page":"F223","volume":"244","author":"DP Simpson","year":"1983","unstructured":"Simpson DP. Citrate excretion: a window on renal metabolism. Am J Phys. 1983;244:F223\u201334.","journal-title":"Am J Phys"},{"key":"2317_CR37","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1093\/ndt\/gfr106","volume":"26","author":"F Mariano","year":"2011","unstructured":"Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M, et al. Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transplant. 2011;26:3882\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"2317_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrc.2013.10.015","volume":"29","author":"D Khadzhynov","year":"2014","unstructured":"Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer HH, et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care. 2014;29:265\u201371.","journal-title":"J Crit Care"},{"key":"2317_CR39","doi-asserted-by":"publisher","first-page":"e65992","DOI":"10.1371\/journal.pone.0065992","volume":"8","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Xu Z, Zhu Q, Liu J, Qian J, You H, et al. Citrate pharmacokinetics in critically ill patients with acute kidney injury. PLoS One. 2013;8:e65992.","journal-title":"PLoS One"},{"key":"2317_CR40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13054-017-1880-1","volume":"21","author":"AG Schneider","year":"2017","unstructured":"Schneider AG, Journois D, Rimmele T. Complications of regional citrate anticoagulation: accumulation or overload? Crit Care. 2017;21:281.","journal-title":"Crit Care"},{"key":"2317_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000420221","volume":"93","author":"RL Mehta","year":"1991","unstructured":"Mehta RL, McDonald BR, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 month. Contrib Nephrol. 1991;93:210\u20134.","journal-title":"Contrib Nephrol"},{"key":"2317_CR42","doi-asserted-by":"publisher","first-page":"c131","DOI":"10.1159\/000079171","volume":"97","author":"S Morgera","year":"2004","unstructured":"Morgera S, Scholle C, Voss G, Haase M, Vargas-Hein O, Krausch D, et al. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract. 2004;97:c131\u20136.","journal-title":"Nephron Clin Pract"},{"key":"2317_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0009-9120(94)00094-C","volume":"28","author":"J Diaz","year":"1995","unstructured":"Diaz J, Acosta F, Parrilla P, Sansano T, Contreras RF, Bueno FS, et al. Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantation. Clin Biochem. 1995;28:315\u20137.","journal-title":"Clin Biochem"},{"key":"2317_CR44","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jcem-38-5-841","volume":"38","author":"F Llach","year":"1974","unstructured":"Llach F, Weidmann P, Reinhart R, Maxwell MH, Coburn JW, Massry SG. Effect of acute and long-standing hypocalcemia on blood pressure and plasma renin activity in man. J Clin Endocrinol Metab. 1974;38:841\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"2317_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00003246-199202000-00014","volume":"20","author":"GP Zaloga","year":"1992","unstructured":"Zaloga GP. Hypocalcemia in critically ill patients. Crit Care Med. 1992;20:251\u201362.","journal-title":"Crit Care Med"},{"key":"2317_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/bmj.316.7125.140","volume":"316","author":"M Egger","year":"1998","unstructured":"Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ. 1998;316:140\u20134.","journal-title":"BMJ"},{"key":"2317_CR47","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.","journal-title":"BMJ"},{"key":"2317_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/039139880302600403","volume":"26","author":"H Morimatsu","year":"2003","unstructured":"Morimatsu H, Uchino S, Bellomo R, Ronco C. Continuous renal replacement therapy: does technique influence electrolyte and bicarbonate control? Int J Artif Organs. 2003;26:289\u201396.","journal-title":"Int J Artif Organs"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-019-2317-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2317-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T02:03:12Z","timestamp":1582336992000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2317-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2317"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2317-9","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"21 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"22"}}